By targeting NEDD4L, miR-513a-5p reduced the TMZ treatment response of GBM cells, suggesting that IGF-1-induced miR-513a-5p signaling participates in affecting the chemosensitivity of TMZ toward GBM. Here, IGF1 is linked to glioblastoma.